230 related articles for article (PubMed ID: 25534861)
1. Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study.
Harris RN; Moskal JT; Capps SG
J Arthroplasty; 2015 Feb; 30(2):192-5. PubMed ID: 25534861
[TBL] [Abstract][Full Text] [Related]
2. Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012.
Moskal JT; Harris RN; Capps SG
J Arthroplasty; 2015 Mar; 30(3):365-8. PubMed ID: 25458093
[TBL] [Abstract][Full Text] [Related]
3. [Local Application of Tranexamic Acid in Total Hip Arthroplasty Decreases Blood Loss and Consumption of Blood Transfusion].
Lošťák J; Gallo J; Večeřa M; Špička J; Langová K
Acta Chir Orthop Traumatol Cech; 2017; 84(4):254-262. PubMed ID: 28933328
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty.
Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ
J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909
[TBL] [Abstract][Full Text] [Related]
5. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
[TBL] [Abstract][Full Text] [Related]
6. Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total hip arthroplasty.
Wei W; Wei B
J Arthroplasty; 2014 Nov; 29(11):2113-6. PubMed ID: 25155138
[TBL] [Abstract][Full Text] [Related]
7. Blood loss and cost-effectiveness of oral vs intravenous tranexamic acid in primary total hip arthroplasty: A randomized clinical trial.
Wu Y; Zeng Y; Hu Q; Li M; Bao X; Zhong J; Shen B
Thromb Res; 2018 Nov; 171():143-148. PubMed ID: 30312799
[TBL] [Abstract][Full Text] [Related]
8. Comparing Cost, Efficacy, and Safety of Intravenous and Topical Tranexamic Acid in Total Hip and Knee Arthroplasty.
DiBlasi JF; Smith RP; Garavaglia J; Quedado J; Frye BM; Dietz MJ
Am J Orthop (Belle Mead NJ); 2016; 45(7):E439-E443. PubMed ID: 28005108
[TBL] [Abstract][Full Text] [Related]
9. Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty.
Tuttle JR; Ritterman SA; Cassidy DB; Anazonwu WA; Froehlich JA; Rubin LE
J Arthroplasty; 2014 Aug; 29(8):1512-5. PubMed ID: 24630599
[TBL] [Abstract][Full Text] [Related]
10. Topical vs Intravenous Tranexamic Acid in Primary Total Hip Arthroplasty: A Double-Blind, Randomized Controlled Trial.
North WT; Mehran N; Davis JJ; Silverton CD; Weir RM; Laker MW
J Arthroplasty; 2016 May; 31(5):1022-6. PubMed ID: 26703193
[TBL] [Abstract][Full Text] [Related]
11. Effect of Tranexamic Acid on Transfusion Rates Following Total Joint Arthroplasty: A Cost and Comparative Effectiveness Analysis.
Evangelista PJ; Aversano MW; Koli E; Hutzler L; Inneh I; Bosco J; Iorio R
Orthop Clin North Am; 2017 Apr; 48(2):109-115. PubMed ID: 28336035
[TBL] [Abstract][Full Text] [Related]
12. Topical Tranexamic Acid is Equivalent to Targeted Preoperative Autologous Blood Donation in Total Hip Arthroplasty.
Kasparek MF; Faschingbauer M; Waldstein W; Boettner CS; Boettner F
J Arthroplasty; 2017 Apr; 32(4):1176-1179. PubMed ID: 27913130
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid: optimal blood loss management in surface replacement arthroplasty.
Sassoon A; Nam D; Jackups R; Johnson SR; Nunley RM; Barrack RL
Bone Joint J; 2016 Feb; 98-B(2):173-8. PubMed ID: 26850421
[TBL] [Abstract][Full Text] [Related]
14. The effect of tranexamic acid on transfusion rate in primary total hip arthroplasty.
Wind TC; Barfield WR; Moskal JT
J Arthroplasty; 2014 Feb; 29(2):387-9. PubMed ID: 23790499
[TBL] [Abstract][Full Text] [Related]
15. Single-dose tranexamic acid for reducing bleeding and transfusions in total hip arthroplasty: A double-blind, randomized controlled trial of different doses.
Wang C; Kang P; Ma J; Yue C; Xie J; Pei F
Thromb Res; 2016 May; 141():119-23. PubMed ID: 27016618
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tranexamic acid in unilateral major revision total hip arthroplasty.
Mei L; Li H; Zhu W; Luo Y; Mao X
Ann Palliat Med; 2020 Sep; 9(5):2466-2473. PubMed ID: 32921073
[TBL] [Abstract][Full Text] [Related]
17. A comparison of combined intravenous and topical administration of tranexamic acid with intravenous tranexamic acid alone for blood loss reduction after total hip arthroplasty: A meta-analysis.
Liu X; Liu J; Sun G
Int J Surg; 2017 May; 41():34-43. PubMed ID: 28336258
[TBL] [Abstract][Full Text] [Related]
18. Tranexamic Acid Benefits Total Joint Arthroplasty Patients Regardless of Preoperative Hemoglobin Value.
Whiting DR; Duncan CM; Sierra RJ; Smith HM
J Arthroplasty; 2015 Dec; 30(12):2098-101. PubMed ID: 26115982
[TBL] [Abstract][Full Text] [Related]
19. Clinical experience with tranexamic acid during primary total hip arthroplasty.
March GM; Elfatori S; Beaulé PE
Hip Int; 2013; 23(1):72-9. PubMed ID: 23397201
[TBL] [Abstract][Full Text] [Related]
20. An Aprotinin Containing Fibrin Sealant Does Not Reduce Blood Loss in Total Hip Arthroplasty.
Kearns SM; Kuhar HN; Bohl DD; Levine BR
J Arthroplasty; 2017 Nov; 32(11):3445-3448. PubMed ID: 28648705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
